Spots Global Cancer Trial Database for Adjuvant Colon Cancer w/ ELOXatin®/5 FU Based Regimen: ACCELOX
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Adjuvant Colon Cancer w/ ELOXatin®/5 FU Based Regimen: ACCELOX
Official Title: Adjuvant Colon Cancer With ELOXatin®/5 FU Based Regimen: ACCELOX
Study ID: NCT01310972
Conditions
Interventions
Study Description
Brief Summary: Adjuvant Colon Cancer With ELOXatin®/5 FU Based Regimen: ACCELOX
Detailed Description: It's a study of adjuvant colon carcinoma using ELOXatin/5-FU based chemotherapeutic regimen called ACCELOX as a definitive curative therapy.
Keywords
Eligibility
Minimum Age: 14 Years
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Kfsh & Rc, Riyadh, , Saudi Arabia
Contact Details
Name: Al Jubran, M.D.
Affiliation: KFSH & RC
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
